Titan Pharmaceuticals, Inc. Operating Lease, Expense
Titan Pharmaceuticals, Inc. reported Operating Lease, Expense of $300.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2020-03-30
- Titan Pharmaceuticals, Inc. operating lease, expense for fiscal 2019 was $300.00K.
| Period end | Operating Lease, Expense 12 month |
|---|---|
| 2019-12-31 | $300.00K 10-K · filed 2020-03-30 |